Exchange Rates 2012

Return to Exchange Rates

Table of Contents

1. January 2012
2. February 2012
3. March 2012
4. April 2012
5. May 2012
6. June 2012
7. July 2012
8. August 2012
9. September 2012
10. October 2012
11. November 2012
12. December 2012

January 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2011 will be used in the review of prices for existing medicines in the second half of 2011.

The international prices of an existing drug product for the period January to December 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2011, the exchange rates used are Dec 2011 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

February 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2011 will be used in the review of prices for existing medicines in the second half of 2011.

The international prices of an existing drug product for the period January to December 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2011, the exchange rates used are Dec 2011 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

March 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2011 will be used in the review of prices for existing medicines in the second half of 2011.

The international prices of an existing drug product for the period January to December 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2011, the exchange rates used are Dec 2011 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

April 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2011 will be used in the review of prices for existing medicines in the second half of 2011.

The international prices of an existing drug product for the period January to December 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2011, the exchange rates used are Dec 2011 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

May 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2011 will be used in the review of prices for existing medicines in the second half of 2011.

The international prices of an existing drug product for the period January to December 2011 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2011, the exchange rates used are Dec 2011 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

June 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2012 will be used in the review of prices for existing medicines in the first half of 2012.

The international prices of an existing drug product for the period January to June 2012 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-months period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2011, the exchange rates used are Dec 2011 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

July 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2012 will be used in the review of prices for existing medicines in the first half of 2012.

The international prices of an existing drug product for the period January to June 2012 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2011, the exchange rates used are Dec 2011 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

August 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2012 will be used in the review of prices for existing medicines in the first half of 2012.

The international prices of an existing drug product for the period January to June 2012 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in Dec 2011, the exchange rates used are Dec 2011 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

September 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2012 will be used in the review of prices for existing medicines in the first half of 2012.

The international prices of an existing drug product for the period January to June 2012 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in May 2012, the exchange rates used are May 2012 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

October 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2012 will be used in the review of prices for existing medicines in the first half of 2012.

The international prices of an existing drug product for the period January to June 2012 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in May 2012, the exchange rates used are May 2012 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

November 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending June 2012 will be used in the review of prices for existing medicines in the first half of 2012.

The international prices of an existing drug product for the period January to June 2012 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in May 2012, the exchange rates used are May 2012 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.

December 2012

The methodology for calculating exchange rates for purposes of the PMPRB´s International Price Comparisons is described in Schedules 6 and 7 of the Compendium of Policies, Guidelines and Procedures, which came into effect on January 1, 2010 (previously under Schedule 3 of the Compendium of Guidelines, Policies and Procedures).

Existing Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending December 2012 will be used in the review of prices for existing medicines in the second half of 2012.

The international prices of an existing drug product for the period January to December 2012 can be converted to Canadian currency for comparison purposes by multiplying the local currency price in each country by the corresponding simple average exchange rate.

New Drug Products

The simple average of the monthly average noon spot exchange rates for each country for the 36-month period ending four months before the date of the first sale of the drug product. The average exchange rates in the following table reflect the PMPRB methodology.

e.g.: A new drug product first sold in May 2012, the exchange rates used are May 2012 since the following table includes four months before the date of the first sale of the drug product as per Guidelines.